![](/img/cover-not-exists.png)
5053 POSTER Randomized Phase III Study of First-line Bevacizumab in Combination With Capecitabine or Paclitaxel for HER2-negative LR/MBC: Interim Safety Data
Inbar, M., Lang, I., Kahán, Z., Greil, R., Beslija, S., Stemmer, S.M., Kaufman, B., Zvirbule, Z., Steger, G.G., Zielinski, C.C.Volume:
47
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(11)71495-2
Date:
September, 2011
File:
PDF, 42 KB
english, 2011